GlycoMimetics stockholders approve 2.6M share increase to equity incentive plan

CRESCENT BIOPHARMA, INC.

Stockholders approved amendment to 2013 Equity Incentive Plan, increasing share reserve by 2,619,622 shares.
All three director nominees (Scott Jackson, Scott Koenig, Harout Semerjian) were elected.
Ratification of Ernst & Young as independent auditor passed with 38,971,830 votes for.
Advisory vote on executive compensation approved with 27,132,991 votes for.
Annual meeting had 75% of shares present or represented.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.